-
1 Comment
Shanghai Kehua Bio-Engineering Co.,Ltd is currently in a long term downtrend where the price is trading 0.3% below its 200 day moving average.
From a valuation standpoint, the stock is 75.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Shanghai Kehua Bio-Engineering Co.,Ltd's total revenue rose by 71.0% to $1B since the same quarter in the previous year.
Its net income has increased by 3686.3% to $209M since the same quarter in the previous year.
Finally, its free cash flow grew by 2964.7% to $429M since the same quarter in the previous year.
Based on the above factors, Shanghai Kehua Bio-Engineering Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE000001KC9 |
| PE Ratio | None |
|---|---|
| Target Price | 12.22 |
| Beta | 0.58 |
| Market Cap | 3B |
| Dividend Yield | None |
Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally. It offers signature products, including immunoassay & clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management, and automated comprehensive solutions for nucleic acid blood screening; automatic modular and clinical chemistry analyzer; automatic chemiluminescence immunoassay analyzers; and CLIA reagents tests. The company also provides automatic microplate reader, microplate washer, and enzyme-linked immunoassay reagents; diagnostic kit for HIV and SARS-CoV-2 IgM/IgG antibody; and fully automated nucleic acid blood screening laboratory and molecular diagnostics solutions. It serves hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. The company also exports its products. Shanghai Kehua Bio-Engineering Co.,Ltd was founded in 1981 and is headquartered in Shanghai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002022.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
